Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions

Obstetrics and Gynecology

Volumn 102, Issue 1, 2003, Pages 167-172

  Schoen, Edgar ^a   Norem, Carol ^a   O'Keefe, Jennifer ^a   Krieger, Robyn ^a   Walton, David ^a   To, Trinh T ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRIOL; STERYL SULFATASE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME DEFICIENCY; ESTRIOL BLOOD LEVEL; FEMALE; FETUS DEATH; FETUS DISEASE; HUMAN; ICHTHYOSIS; MATERNAL SERUM; NEWBORN MORTALITY; OLIGOHYDRAMNIOS; PREDICTION; PRENATAL DIAGNOSIS; PRENATAL SCREENING; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME; THERAPEUTIC ABORTION;

EID: 0038384014     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(03)00370-3     Document Type: Article

References (24)

1. Irons M., Elias E.R., Salen G., Tint G.S., Batta A.K. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet. 341:1993;1414.
2. Tint G.S., Irons M., Elias E.R., Batta A.K., Frieden R., Chen T.S., et al. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med. 330:1994;107-113.
3. Abuelo D.N., Tint G.S., Kelley R., Batta A.K., Shefer S., Salen G. Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols. Am J Med Genet. 56:1995;281-285.
4. Tint G.S., Abuelo D., Till M., Cordier M.P., Batta A.K., Shefer S., et al. Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols. Prenat Diagn. 18:1998;651-658.
5. Kratz L.E., Kelley R.I. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome. Am J Med Genet. 82:1999;376-381.
6. Nowaczyk M.J., McCaughey D., Whelan D.T., Porter F.D. Incidence of Smith-Lemli-Opitz syndrome in Ontario, Canada. Am J Med Genet. 102:2001;18-20.
7. Ryan A.K., Bartlett K., Clayton P., Eaton S., Mills L., Donnai D., et al. Smith-Lemli-Opitz syndrome A variable clinical and biochemical phenotype . J Med Genet. 35:1998;558-565.
8. Smith D.W., Lemli L., Opitz J.M. A newly recognized syndrome of multiple congenital anomalies. J Pediatr. 64:1964;210-217.
9. Curry C.J., Carey J.C., Holland J.S., Chopra D., Fineman R., Golabi M., et al. Smith-Lemli-Opitz syndrome-type II Multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality . Am J Med Genet. 26:1987;45-57.
10. Cunniff C., Kratz L.E., Moser A., Natowicz M.R., Kelley R.I. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism. Am J Med Genet. 68:1997;263-269.
11. Kelley R.I. A new face for an old syndrome. Am J Med Genet. 68:1997;251-256.
12. Opitz J.M. RSH (so-called Smith-Lemli-Opitz) syndrome. Curr Opin Pediatr. 11:1999;353-362.
13. Shackleton C.H., Roitman E., Kratz L.E., Kelley R.I. Equine type estrogens produced by a pregnant woman carrying a Smith-Lemli-Opitz syndrome fetus. J Clin Endocrinol Metab. 84:1999;1157-1159.
14. Angle B., Tint G.S., Yacoub O.A., Clark A.L. A typical case of Smith-Lemli-Opitz syndrome Implications for diagnosis . Am J Med Genet. 80:1998;322-326.
15. Blitzer M.G., Kelley R.I., Schwartz M.F. Abnormal maternal serum marker pattern associated with Smith-Lemli-Opitz (SLO) syndrome. Am J Hum Genet. 55:1994;A277.
16. David M., Isreal N., Merksamer R., Bar-Nizan N., Borochowitz Z., Bar-el H., et al. Very low maternal serum unconjugated estriol andprenatal diagnosis of steroid sulfatasedeficiency. Fetal Diagn Ther. 10:1995;76-79.
17. Schleifer R.A., Bradley L.A., Richards D.S., Ponting N.R. Pregnancy outcome for women with very low levels of maternal serum unconjugated estriol on second-trimester screening. Am J Ostet Gynecol. 173:1995;1152-1156.
18. Bradley L.A., Canick J.A., Palomaki G.E., Haddow J.E. Undetectable maternal serum unconjugated estriol levels in the second trimester Risk of perinatal complications associated with placental sulfatase deficiency . Am J Obstet Gynecol. 176:1997;531-535.
19. Palomaki G.E., Bradley L.A., Knight G.J., Craig W.Y., Haddow J.E. Assigning risk for Smith-Lemli-Optiz syndrome as part of 2nd trimester screening for Down's syndrome. J Med Screen. 9:2002;43-44.
20. Kelley R.I., Hennekam R.C. The Smith-Lemli-Optiz syndrome. J Med Genet. 37:2000;321-335.
21. Kelley R.I., Herman G.E. Inborn errors of sterol biosynthesis. Annu Rev Genomics Hum Genet. 2:2001;299-341.
22. Bartles I., Caesar J., Sancken U. Prenatal detection of X-linked ichthyosis by maternal serum screening for Down syndrome. Prenat Diagn. 14:1994;227-229.
23. Glass I.A., Lam R.C., Chang T., Roitman E., Shapiro L.J., Shackleton C.H. Steroid sulphatase deficiency is the major cause of extremely low oestriol production at mid-pregnancy A urinary steroid assay for the discrimination of steroid sulphatase deficiency from other causes . Prenat Diagn. 18:1998;789-800.
24. Paige D.G., Emilion G.G., Bouloux P.M., Hatper J.I. A clinical and genetic study of X-linked recessive ichthyosis and contiguous gene defects. Br J Dermatol. 131:1994;662-669.